NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $123.16 -2.19 (-1.75%) Closing price 04:00 PM EasternExtended Trading$123.44 +0.28 (+0.23%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$123.01▼$126.7950-Day Range$101.79▼$128.1252-Week Range$100.85▼$212.00Volume534,237 shsAverage Volume620,511 shsMarket Capitalization$4.06 billionP/E RatioN/ADividend YieldN/APrice Target$179.93Consensus RatingModerate Buy Company Overview iRhythm Technologies, Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians. The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions. iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.AI Generated. May Contain Errors. Read More iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 83% of companies evaluated by MarketBeat, and ranked 107th out of 911 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.94, and is based on 2 strong buy ratings, 12 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialiRhythm Technologies has a consensus price target of $179.93, representing about 43.1% upside from its current price of $125.76.Amount of Analyst CoverageiRhythm Technologies has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth216.28% Earnings GrowthEarnings for iRhythm Technologies are expected to grow by 216.28% in the coming year, from $0.43 to $1.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -291.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -291.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 22.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted9.84% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.62.Change versus previous monthShort interest in iRhythm Technologies has recently decreased by 6.34%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.55 News SentimentiRhythm Technologies has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 33 news articles for iRhythm Technologies this week, compared to 6 articles on an average week.Search Interest2 people have searched for IRTC on MarketBeat in the last 30 days. MarketBeat Follows1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders0.98% of the stock of iRhythm Technologies is held by insiders.Percentage Held by InstitutionsiRhythm Technologies has minimal institutional ownership at this time.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRTC Stock News HeadlinesTruist Financial Sticks to Their Buy Rating for Irhythm Technologies (IRTC)August 12 at 4:54 PM | theglobeandmail.comiRhythm Technologies (NASDAQ:IRTC) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 12 at 3:02 AM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.August 13 at 1:00 AM | Base Camp Trading (Ad)Truist Financial Boosts iRhythm Technologies (NASDAQ:IRTC) Price Target to $168.00August 12 at 1:54 AM | americanbankingnews.comWhy iRhythm (IRTC) shares are trading lower todayAugust 11 at 1:00 AM | msn.comiRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer SaysAugust 10 at 2:59 PM | finance.yahoo.comWells Fargo & Company Cuts iRhythm Technologies (NASDAQ:IRTC) Price Target to $168.00August 10 at 3:31 AM | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Earnings BeatAugust 9, 2026 | americanbankingnews.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $177.44 at the start of the year. Since then, IRTC stock has decreased by 29.1% and is now trading at $125.7550. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies (NASDAQ:IRTC) posted its quarterly earnings data on Thursday, August, 6th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.62. iRhythm Technologies's revenue was up 20.1% on a year-over-year basis. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $88 million in an IPO on Thursday, October 20th 2016. The company issued 6,294,118 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? Top institutional shareholders of iRhythm Technologies include Covington Investment Advisors Inc. (0.26%), Citizens Financial Group Inc. RI (0.15%), Assenagon Asset Management S.A. (0.07%) and Handelsbanken Fonder AB (0.04%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Chad Patterson, Minang Turakhia, Sumi Shrishrimal, Daniel G Wilson, Mervin Smith, Abhijit Y Talwalkar, Brice Bobzien, Marc Wade Rosenbaum and Marc W Rosenbaum. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings8/06/2026Today8/13/2026Next Earnings (Estimated)10/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 IRTC's financial health is in the Red zone, according to TradeSmith. IRTC has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Price Target for iRhythm Technologies$179.93 High Price Target$220.00 Low Price Target$147.00 Potential Upside/Downside+45.7%Consensus RatingModerate Buy Rating Score (0-4)2.94 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E Ratio287.17 P/E GrowthN/ANet Income-$44.55 million Net Margins-1.69% Pretax Margin-1.57% Return on Equity10.11% Return on Assets1.53% Debt Debt-to-Equity Ratio3.50 Current Ratio3.86 Quick Ratio3.74 Sales & Book Value Annual Sales$747.14 million Price / Sales5.45 Cash FlowN/A Price / Cash FlowN/A Book Value$5.64 per share Price / Book21.89Miscellaneous Outstanding Shares32,960,000Free Float32,640,000Market Cap$4.07 billion OptionableOptionable Beta1.30 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:IRTC) was last updated on 8/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRTC Stock Alerts